Cargando…
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
Although genetic factors contribute to almost half of all deafness cases, treatment options for genetic deafness are limited(1–5). We developed a genome editing approach to target a dominantly inherited form of genetic deafness. Here we show that cationic lipid-mediated in vivo delivery of Cas9:guid...
Autores principales: | Gao, Xue, Tao, Yong, Lamas, Veronica, Huang, Mingqian, Yeh, Wei-Hsi, Pan, Bifeng, Hu, Yu-Juan, Hu, Johnny H., Thompson, David B., Shu, Yilai, Li, Yamin, Wang, Hongyang, Yang, Shiming, Xu, Qiaobing, Polley, Daniel B., Liberman, M. Charles, Kong, Wei-Jia, Holt, Jeffrey R., Chen, Zheng-Yi, Liu, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784267/ https://www.ncbi.nlm.nih.gov/pubmed/29258297 http://dx.doi.org/10.1038/nature25164 |
Ejemplares similares
-
Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing
por: Zheng, Ziwen, et al.
Publicado: (2022) -
RNA Interference Prevents Autosomal-Dominant Hearing Loss
por: Shibata, Seiji B., et al.
Publicado: (2016) -
Precise detection of CRISPR-Cas9 editing in hair cells in the treatment of autosomal dominant hearing loss
por: Cui, Chong, et al.
Publicado: (2022) -
Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss
por: György, Bence, et al.
Publicado: (2019) -
Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo
por: Tao, Yong, et al.
Publicado: (2023)